Start › Niedrobnokomórkowy rak płuca › Waszyngton › Tacoma
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Tacoma, WA
20 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Tacoma i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
RekrutacjaFaza 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · 8 mi dalej
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · 8 mi dalej
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekrutacjaFaza 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · 26 mi dalej
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekrutacjaFaza 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi dalej
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi dalej
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekrutacjaFaza 3
- Vista Oncology Inc PS, Olympia · 26 mi dalej
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi dalej
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi dalej
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- Vista Oncology, Olympia · 26 mi dalej
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekrutacjaFaza 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
RekrutacjaBadanie obserwacyjne
- Northwest Medical Specialties (NWMS), Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekrutacjaFaza 3
- Local Institution - 0499, Lacey · 23 mi dalej
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Tacoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 3
- Research Site, Tacoma
- Research Site, Olympia · 26 mi dalej
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · 26 mi dalej
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekrutacjaFaza 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekrutacjaFaza 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · 8 mi dalej
- i 3 więcej
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekrutacjaFaza 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi dalej
- MultiCare Regional Cancer Center, Puyallup · 8 mi dalej
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekrutacjaFaza 2
- USA09-0, Puyallup · 8 mi dalej
BostonGene and Exigent Genomic INsight Study
RekrutacjaBadanie obserwacyjne
- Northwest Medical Specialities, Puyallup · 8 mi dalej
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY120 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH56 badań
- Washington, DC55 badań
Inne badania w mieście Tacoma
- Rak piersi18 badań
- Wrzodziejące zapalenie jelita grubego15 badań
- Szpiczak mnogi13 badań
- Rak prostaty11 badań
- Choroba Leśniowskiego-Crohna11 badań
- Nowotwór przerzutowy9 badań
- Rak jelita grubego i odbytnicy9 badań
- Czerniak7 badań
- Rak jajnika7 badań
- Nowotwory (wszystkie typy)6 badań
- Rak trzustki6 badań
- Otyłość6 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.